Navigation Links
Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
Date:10/11/2007

Dr. Daniel Weiner Will Discuss Challenges and Opportunities to Realize

Critical Path Initiative Goals

MOUNTAIN VIEW, Calif., Oct. 11 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Daniel Weiner, Ph.D., senior vice president and chief technology officer, has been invited to speak to U.S. and Japanese biopharmaceutical executives attending a session on research and development productivity hosted by the New York Pharma Forum (NYPF), to be held in New York City, October 15, 2007.

Dr. Weiner's presentation will discuss the technical, organizational and process changes needed to reach the goals of the FDA's Critical Path Initiative for improving drug development productivity, including opportunities for the adoption of quantitative drug-disease modeling and simulation. Dr. Weiner will join other industry experts as part of the NYPF program entitled "R&D Productivity: Are There Winning Strategies?" The session will also offer a forum for interdisciplinary discussion on areas of opportunity in the drug development and approval process.

"Pharsight has built a strong reputation for providing critical solutions that increase productivity in the drug development industry," said Shawn O'Connor, president, chief executive officer, and chairman of Pharsight. "Through our strategic consulting services and growing family of software products, we have successfully collaborated with global drug developers to incorporate modeling and simulation into their development processes. These collaborations have yielded a number of success stories, ranging from increased efficiencies and more confident decision-making to better resource management. Pharsight is pleased to participate at this NYPF event, and to offer its perspectives on opportunities, challenges and supporting t
'/>"/>

SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Why companies dont get invited to the DEMO conference
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...PRNewswire-FirstCall/ -- Palatin Technologies, Inc... Patent and Trademark Office has issued U.S. Paten...e Constructs." The claims in the issued patent co...iuretic peptide receptor A (NPRA), including PL-39..., "Our natriuretic compounds, including PL-3994...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- Medizone International, I...t in tests involving its proprietary AsepticSure(T...tamination barriers, this time with two very diffe...e and Bacillis subtilis. These results clearly est...icidal technology. "The implications of a 6.7 log ...
(Date:12/1/2009)...manitarian organizations will collaborate in compr...epair technologies. Their shared efforts will begi...ogo. , Dallas, TX (PRWEB)...Memorandum of Understanding, Mercy Ships and MediS... help develop sustainable infrastructure in hospit...
(Date:11/30/2009)...09 An international team of applied scientists fr...e demonstrated compact, multibeam, and multi-wavel... light spectrum (infrared). By contrast, typical l...avelength. The innovative multibeam lasers have po...ical sensing pollution monitoring, optical wireles...
Breaking Biology Technology:Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 3Scientists demonstrate multibeam, multi-functional lasers 2
... Thermo Fisher,Scientific Inc. (NYSE: TMO ), the...venues increased 9% to a record $2.55 billion in t...e 2007 quarter. Currency translation,increased rev..., increased,revenues by 1%. GAAP diluted earnings ...he year-ago period. GAAP operating income for the ...
... 24, 2008 / b3c newswire / - Sloning BioTechnolog...versity are working on a project to synthesize a g...duced in a statistically expected and controlled r...equence., ,Sloning will utilize its core technolo...tform using defined sets of double stranded DNA tr...
...dys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announce...ancial results on Wednesday, April 30, 2008, after...old a conference call and webcast to discuss its f... and to provide an update on,its development progr...ern,Daylight Time. A live webcast of the call will...
Other Biology Technology:Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 2Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 3Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 5Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 6Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 7Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 8Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 9Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 10Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 11Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 12Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 13Sloning and the Kornberg group at Stanford University starting evaluation project regarding the synthesis of a Statistically Randomized Gene Library 2Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 2
(Date:11/30/2009)... are crucial for infection. Each binds a specific ...ulates the host cell to take up the pathogen. Norm...unction, for example the regulation of cell growth...een published in the current issue of the " Journa...of the sources for Listeria infections leading t...
(Date:11/30/2009)...ird registration rates and register online now for...tp://www.iofwco-ecceo10.org/ , WHAT: IOF WCO-E...teoporosis Foundation (IOF) and the European Socie...is and Osteoarthritis (ESCEO). More than 5,000 par...tend. The exciting scientific programme includes 1...
(Date:11/30/2009)...of seeing your extended family over the holidays w...rt in the December 2009 print issue of the Journa...) shows that you might be right. Here,s the good n...irely new treatments that help keep autoimmune dis...rol. That,s because researchers from the Universit...
Breaking Biology News(10 mins):It takes 2 to infect 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Wildlife Conservation Society supports worlds first study of egg laying mammal 8776 1Wildlife Conservation Society supports worlds first study of egg laying mammal 8776 2Wildlife Conservation Society supports worlds first study of egg laying mammal 8776 3Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 1Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 2Donor Stem Cell Transplant Best For Acute Myeloid Leukemia 48368 3Nonin Medical Inc Announces the First Bluetooth 28R 29 Continua 28TM 29 Certified Product 48365 1Nonin Medical Inc Announces the First Bluetooth 28R 29 Continua 28TM 29 Certified Product 48365 2
... Research being presented today (10 April) at the ...ng in Edinburgh represents a step towards the use ...e. Speaking at the conference in Edinburgh, Profe...scribes how she and her team have uncovered a mess...tissue repair in response to chemical signals in t...
... NASA scientist Waleed Abdalati, one of the world,...te change, will present Dramatic Changes in Earth,...0 p.m., Thursday, April 10, in the Gore Recital Ha...Arts at UD. , As head of NASA,s Cryospheric Scien...ho work with satellites and aircraft instruments t...
..., University of Delaware researchers, in collabora...found a new type of molecule--a kind of micro-swit...primary source of food for more than half the worl...arch 25 issue of the Proceedings of the National A.... , Composed of short lengths of ribonucleic acid...
Other Biology News:Scientists uncover the potential to control adult stem cells 2UD researchers discover novel 'gene toggles' in world's top food crop 2UD researchers discover novel 'gene toggles' in world's top food crop 3
Rabbit Anti-Human ADAMTS16 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Mouse Anti-Mouse Ly 6C.2(Ly 28.2) Monoclonal Antibody, Unconjugated, Clone 5075-3.6 from CEDARLANE Laboratories Limited
Biology Products: